These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6944256)

  • 21. Mechanism of action of the nitrosoureas--IV. Reactions of bis-chloroethyl nitrosourea and chloroethyl cyclohexyl nitrosourea with deoxyribonucleic acid.
    Gombar CT; Tong WP; Ludlum DB
    Biochem Pharmacol; 1980 Oct; 29(19):2639-43. PubMed ID: 7191706
    [No Abstract]   [Full Text] [Related]  

  • 22. The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours.
    Connors TA; Hare JR
    Br J Cancer; 1974 Nov; 30(5):477-80. PubMed ID: 4469198
    [No Abstract]   [Full Text] [Related]  

  • 23. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymes.
    Potter DW; Levin W; Ryan DE; Thomas PE; Reed DJ
    Biochem Pharmacol; 1984 Feb; 33(4):609-13. PubMed ID: 6704177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of carbamoylated thiol conjugates as metabolites of the antineoplastic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, in rats and humans.
    Borel AG; Abbott FS
    Drug Metab Dispos; 1993; 21(5):889-901. PubMed ID: 7902253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procarbazine hydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():311-39. PubMed ID: 6792050
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
    Siemann DW
    Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
    Kohlhepp SJ; May HE; Reed DJ
    Drug Metab Dispos; 1981; 9(2):135-41. PubMed ID: 6113112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins.
    Woolley PV; Dion RL; Kohn KW; Bono VH
    Cancer Res; 1976 Apr; 36(4):1470-4. PubMed ID: 4221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dacarbazine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():203-15. PubMed ID: 6944259
    [No Abstract]   [Full Text] [Related]  

  • 30. Isophosphamide.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():237-47. PubMed ID: 6944261
    [No Abstract]   [Full Text] [Related]  

  • 31. Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.
    Tator CH
    Surg Neurol; 1977 Feb; 7(2):73-7. PubMed ID: 835077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorinated analogues of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea: an attempt to control metabolism.
    Foster AB; Jarman M; Coe PL; Sleigh J; Tatlow JC
    J Med Chem; 1980 Nov; 23(11):1226-9. PubMed ID: 7452672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with combination therapy of solid tumors using 1-(2-chloroethyl)-3-cyclohexyl-nitrosourea--CCNU].
    Robustelli Della Cuna G
    G Ital Chemioter; 1980; 27(1):15-8. PubMed ID: 7286538
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclophosphamide.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():165-202. PubMed ID: 6944258
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of specific-locus and dominant lethal mutations in male mice by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Ehling UH; Adler ID; Favor J; Neuhäuser-Klaus A
    Mutat Res; 1997 Oct; 379(2):219-31. PubMed ID: 9357551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats.
    Russo RG; Cattaneo MT; Bartosek I
    Tumori; 1984 Dec; 70(6):499-502. PubMed ID: 6531792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
    Levin VA; Kabra PA; Freeman-Dove MA
    Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Waldbaur H; Kuschnir H; Engelmann U; Schmidt H; Schmack B
    Acta Neurochir (Wien); 1978; 42(1-2):103-8. PubMed ID: 696438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prednisone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():293-309. PubMed ID: 6944264
    [No Abstract]   [Full Text] [Related]  

  • 40. Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Babson JR; Reed DJ; Sinkey MA
    Biochemistry; 1977 Apr; 16(8):1584-9. PubMed ID: 856251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.